Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 138 M127 M134 M130 M149 M 540 M Research & development ————— — Operating income 624 M427 M619 M704 M412 M 2.16 B Non-Operating Income, Total -197 M-197 M-206 M-224 M-223 M -850 M Interest expense, net of interest capitalized 250 M256 M271 M279 M293 M 1.1 B Non-Operating Income, excl. Interest Expenses -447 M-453 M-477 M-503 M-516 M -1.95 B Unusual income/expense 30 M34 M39 M26 M39 M 138 M Pretax income 427 M230 M413 M480 M189 M 1.31 B Equity in earnings 7 M4 M5 M31 M3 M 43 M Taxes -18 M1 M-6 M111 M-58 M 48 M Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations 445 M229 M419 M369 M247 M 1.26 B Discontinued operations ————— — Net income 445 M229 M419 M369 M247 M 1.26 B Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 444 M228 M418 M369 M247 M 1.26 B Basic earnings per share (Basic EPS) 2.141.12.021.781.19 6.09 Diluted earnings per share (Diluted EPS) 2.141.12.011.781.19 6.08 Average basic shares outstanding 207 M207 M207 M207 M207 M — Diluted shares outstanding 207 M207 M207 M207 M208 M — EBITDA 1.08 B878 M1.08 B1.18 B895 M 4.03 B EBIT 624 M427 M619 M704 M412 M 2.16 B Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) 452 M451 M464 M474 M483 M 1.87 B